BioIncubate Kickoff Event
Join the Bioincubate challenge | Keynote talks | Networking | Apéro
Once again we had a great kickoff of the program, both in Zurich and in Basel. After presenting details on our upcoming events and the Ignite and Surge tracks, we got some very insightful talks with Patrick Amstutz, PhD - co-founder and CEO of Molecular Partners, and Julia Wagner, PhD, and Til Schlotter, PhD - co-founders of our last year winner - UNOMR in Zurich, and Natasa Cmiljanovic, PhD - founder of SwissRockets, and the founder and CEO of INNOSIAMO Anne Ulvestad, MSc MBA (more info on the speakers below). We hope everyone enjoyed the kickoff, and we would love to see you soon on our next events!
Explore our 2 startup tracks:
Event timeline:
Oct 2024
Kickoff Event
Nov 2024
Selection Event
Build Phase
May 2025
Pitching Event
Location:
Zurich, Rämistrasse 101
ETH HG D1.1 | HG D Süd (apéro)
Location:
Basel, Hochbergerstr. 60 I
Stücki Park, Superlab Suisse
Zurich Speakers:
Patrick Amstutz, PhD (Zurich)
A graduate of ETH Zurich and the University of Zurich, Patric Amstutz is a co-founder and since 2016 CEO of Molecular Partners AG - a clinical-stage biopharmaceutical company based in Zurich. The company is working on developing therapies centered on DARPins (designed ankyrin repeat proteins) - a research focus of Patrick Amstutz since 2004, with two DARPin molecules already in phase 1 clinical development.
Julia Wagner, PhD, Til Schlotter, PhD and Julian Hengsteler (Zurich)
Last year Julia Wagner, Til Schlotter and Julian Hengsteler joined us at the Bioincubate start-up track programme for 2023, and managed to win first place with their start-up UNOMR! With background in mathematics and mechanical engineering, they are working on hardware and software to combat the difficulties in proteomics by providing an unprecedented in-depth analytical solutions.
Natasa Cmiljanovic, PhD (Basel)
Founder of the Swiss incubator and accelerator Swiss rockets, as well as chief operating officer at its biotech subsidiaries RocketVax and Torqur, Dr. Natasa Cmiljanovic is a medicinal chemist with over a decade of experience in the field of oncology drug discovery and development. With a rich portfolio ranging from drug discovery, preclinical development and clinical research to building, and then evaluating and supporting startups, her expertise will prove very valuable to the new generation of entrepreneurs.
Anne Ulvestad, MSc MBA (Basel)
Anne Ulvestad is the founder and current executive director of INNOSIAMO, a boutique strategy consultancy aimed at young healthcare businesses. She also has over 25 years of experience in the life sciences, having worked at the Friedrich Miescher Institute for Biomedical Research, in lead positions in Novartis, Arctic Pharma and Neuropathy Companion, with a wealth of expertise in project management and operations in developing medicines and diagnostic solutions.
